| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
| mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
4e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-05 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-05 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-05 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
6e-05 |
| mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
| mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-05 |
| mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |